184 related articles for article (PubMed ID: 23463868)
1. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
Sekiguchi Y; Misawa S; Shibuya K; Nasu S; Mitsuma S; Iwai Y; Beppu M; Sawai S; Ito S; Hirano S; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1346-8. PubMed ID: 23463868
[TBL] [Abstract][Full Text] [Related]
2. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
Kanai K; Kuwabara S; Misawa S; Hattori T
Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
[TBL] [Abstract][Full Text] [Related]
3. Does suppression of VEGF alone lead to clinical recovery in POEMS syndrome?
Arimura K
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1301. PubMed ID: 23644502
[No Abstract] [Full Text] [Related]
4. Multiple angiogenetic factors are upregulated in POEMS syndrome.
Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
[TBL] [Abstract][Full Text] [Related]
5. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
Kuwabara S
Nihon Rinsho; 2013 May; 71(5):865-9. PubMed ID: 23777096
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
8. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
[TBL] [Abstract][Full Text] [Related]
9. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
Kuwabara S
Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
[TBL] [Abstract][Full Text] [Related]
10. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Brain Nerve; 2010 Apr; 62(4):395-400. PubMed ID: 20420180
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome.
Buxhofer-Ausch V; Gisslinger B; Stangl G; Rauschka H; Gisslinger H
Leuk Res; 2012 May; 36(5):e98-e100. PubMed ID: 22365941
[No Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome.
Rosti V; Massa M; Campanelli R; De Amici M; Piccolo G; Perfetti V
Haematologica; 2007 Sep; 92(9):1291-2. PubMed ID: 17768134
[TBL] [Abstract][Full Text] [Related]
14. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome.
Perfetti V; Palladini G; De Amici M; Livraghi L; Pedrazzoli P; Merlini G
Ann Hematol; 2013 Aug; 92(8):1133-4. PubMed ID: 23334107
[No Abstract] [Full Text] [Related]
18. [Bevacizumab therapy for Poems syndrome].
Doffoel-Hantz V; Jaccard A; Sparsa A; Girault S; Bonnetblanc JM; Bordessoule D; Bédane C
Ann Dermatol Venereol; 2008 Apr; 135(4):320-1. PubMed ID: 18420085
[No Abstract] [Full Text] [Related]
19. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
20. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Cai H; Zhou D; Li J
Leuk Res; 2016 Nov; 50():78-84. PubMed ID: 27697660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
